Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:52:54.774Z.
Calculation as of: 2026-10-06T14:52:54.774Z.
Quote observation: 2026-10-06T14:49:34.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0dc40ddd6b0c815ea8fb06d6c0f10798674f4babd9a38c246e46e89e51900236
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Lite Strategy, Inc.
Market Cap
$47.81M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$48.99M
Operating Cash Flow Yield
N/A
TTM Avg
10.62%
3Y Avg
10.36%
5Y Avg
10.36%
Market Cap
$50.42M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.25M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$45.32M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$44.84M
Operating Cash Flow Yield
N/A
TTM Avg
11.87%
3Y Avg
9.02%
5Y Avg
6.85%
Market Cap
$44.80M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lite Strategy, Inc. (LITS) | $47.81M | N/A | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $48.34M | N/A | N/A | N/A | N/A |
| Microbot Medical Inc. (MBOT)vs › | $48.99M | N/A | 10.62% | 10.36% | 10.36% |
| Clene Inc. (CLNN)vs › | $49.71M | N/A | N/A | N/A | N/A |
| Apollomics, Inc. (APLM)vs › | $50.42M | N/A | N/A | N/A | N/A |
| INmune Bio, Inc. (INMB)vs › | $50.25M | N/A | N/A | N/A | N/A |
| DarioHealth Corp. (DRIO)vs › | $45.32M | N/A | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $44.84M | N/A | 11.87% | 9.02% | 6.85% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.80M | N/A | N/A | N/A | N/A |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $50.92M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
